RELATLIMAB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Lymphocyte activation gene 3 protein inhibitor | no | 2 | 1 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Lymphocyte activation gene 3 protein inhibitor | no | 2 | 1 |